Human trials of ‘prime and boost’ Ebola vaccine underway The University of Oxford has begun a phase I clinical trial of a preventive Ebola vaccine that uses a ‘prime and boost’ approach.…
2014: The Pharmaceutical Journal’s news in review Looking back at some of the biggest news stories from the past year. …
Evidence still lacking for Ebola treatments, concludes European Medicines Agency Lack of evidence for seven investigational drugs being developed for the treatment of Ebola means it is impossible to make conclusions about their safety or efficacy.…
Use of antiretroviral therapy will drive down HIV virulence HIV is evolving relatively rapidly, which is contributing to a reduction in HIV virulence at the population level, say researchers writing in PNAS.…
Benefits of influenza vaccination19 November 2014: English Pharmacy Board member Sibby Buckle spoke to the Daily Mail to offer advice and tips about staying healthy this winter. Buckle told the paper that it is a good idea to get a flu jab as it’s 95% effective and lasts for a year. She said: “People who’ve n…
Ebola clinical trial suspended after volunteers complain of joint pains A phase I clinical trial of the fast-tracked Ebola vaccine VSV-ZEBOV has been halted in Switzerland because some trial participants developed mild joint pain.…
Pregnant women warned not to stop taking prescribed drugs without medical advice Two-thirds of maternal deaths are due to an unrelated medical or mental health condition which has not been well-controlled rather than from a complication of pregnancy, says a new report.…
EMA says flu vaccine is safe after deaths in ItalyThere is no evidence that Novartis’s Fluad is unsafe, the European Medicines Agency (EMA) says, after 13 deaths in Italy were reported as being associated with the influenza vaccine.…
Pharmacy flu vaccinations increase in Wales Nearly 8,000 people were vaccinated against influenza at Welsh pharmacies in 2013–2014, according to data published by the Welsh Government.…
Time to fast-track the fight against HIVThere are considerable challenges to address if global HIV/AIDS aspirations are to be accelerated.…